Evidence map›Paper›PMID 33431802›Full record

ArticleTranslational psychiatry2021

Clinical and genetic differences between bipolar disorder type 1 and 2 in multiplex families.

Jose Guzman-Parra, Fabian Streit, Andreas J Forstner, Jana Strohmaier, Maria José González, Susana Gil Flores, Francisco J Cabaleiro Fabeiro, Francisco Del Río Noriega, Fermin Perez Perez, Jesus Haro González and 18 more

Open access · goldAbstract read
In one paragraph

Article in Translational psychiatry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors at 10 institutions in 3 countries.

Jose Guzman-Parra *Department of Mental Health, University Regional Hospital of Málaga, Institute of Biomedicine of Málaga (IBIMA), Málaga, Spain.
Fabian Streit *Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.ORCID http://orcid.org/0000-0003-1080-4339
Andreas J ForstnerCentre for Human Genetics, University of Marburg, Marburg, Germany.ORCID http://orcid.org/0000-0002-1876-6368
Jana StrohmaierDepartment of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.ORCID http://orcid.org/0000-0002-4364-1487
Maria José GonzálezDepartment of Mental Health, Hospital of Puerto Real, Cádiz, Spain.
Susana Gil FloresDepartment of Mental Health, University Hospital of Reina Sofia, Cordoba, Spain.
Francisco J Cabaleiro FabeiroDepartment of Mental Health, Hospital of Jaen, Jaen, Spain.
Francisco Del Río NoriegaDepartment of Mental Health, Hospital of Jerez de la Frontera, Jerez de la Frontera, Spain.
Fermin Perez PerezDepartment of Mental Health, Hospital of Puerto Real, Cádiz, Spain.
Jesus Haro GonzálezDepartment of Mental Health, Hospital Punta de Europa, Algeciras, Spain.
Guillermo Orozco DiazUnidad de Gestión Clínica del Dispositivo de Cuidados Críticos y Urgencias del Distrito Sanitario Málaga-Coin-Guadalhorce, Málaga, Spain.
Yolanda de Diego-OteroDepartment of Mental Health, University Regional Hospital of Málaga, Institute of Biomedicine of Málaga (IBIMA), Málaga, Spain.ORCID http://orcid.org/0000-0003-2384-8349
Berta Moreno-KustnerDepartment of Personality, Assessment and Psychological Treatment, University of Malaga, Institute of Biomedicine of Málaga (IBIMA), Málaga, Spain.
Georg AuburgerDepartment of Neurology, Goethe University Medical School, Frankfurt am Main, Germany.
Franziska DegenhardtInstitute of Human Genetics, University of Bonn, School of Medicine & University Hospital Bonn, Bonn, Germany.
Stefanie Heilmann-HeimbachInstitute of Human Genetics, University of Bonn, School of Medicine & University Hospital Bonn, Bonn, Germany.
Stefan HermsInstitute of Human Genetics, University of Bonn, School of Medicine & University Hospital Bonn, Bonn, Germany.ORCID http://orcid.org/0000-0002-2786-8200
Per HoffmannInstitute of Human Genetics, University of Bonn, School of Medicine & University Hospital Bonn, Bonn, Germany.
Josef FrankDepartment of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.ORCID http://orcid.org/0000-0003-4867-9465
Jerome C FooDepartment of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.ORCID http://orcid.org/0000-0003-1067-5725
Lea SirignanoDepartment of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.ORCID http://orcid.org/0000-0002-7989-5833
Stephanie H WittDepartment of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.ORCID http://orcid.org/0000-0002-1571-1468
Sven CichonDepartment of Biomedicine, University of Basel, Basel, Switzerland.
Fabio RivasDepartment of Mental Health, University Regional Hospital of Málaga, Institute of Biomedicine of Málaga (IBIMA), Málaga, Spain.
Fermín MayoralDepartment of Mental Health, University Regional Hospital of Málaga, Institute of Biomedicine of Málaga (IBIMA), Málaga, Spain.
Markus M NöthenInstitute of Human Genetics, University of Bonn, School of Medicine & University Hospital Bonn, Bonn, Germany.
Till F M Andlauer *Department of Neurology, Klinikum rechts der Isar, School of Medicine, Technical University of Munich, Munich, Germany. till.andlauer@tum.de.ORCID http://orcid.org/0000-0002-2917-5889
Marcella Rietschel *Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.ORCID http://orcid.org/0000-0002-5236-6149
Heidelberg University · DEUniversity of Bonn · DEInstituto de Investigación Biomédica de Málaga · ESHospital Universitario Puerto Real · ESComplejo Hospitalario de Jaén · ESForschungszentrum Jülich · DEGoethe University Frankfurt · DEHospital Jerez Puerta del Sur · ESHospital Universitario Reina Sofía · ESTUM Klinikum · DE

Funding

Bundesministerium für Bildung und Forschung (Federal Ministry of Education and Research) 01EE1406CBundesministerium für Bildung und Forschung (Federal Ministry of Education and Research) 01EE1409CBundesministerium für Bildung und Forschung (Federal Ministry of Education and Research) 01ZX1314ABundesministerium für Bildung und Forschung (Federal Ministry of Education and Research) 01ZX1314GBundesministerium für Bildung und Forschung (Federal Ministry of Education and Research) 01ZX1614GBundesministerium für Bildung und Forschung (Federal Ministry of Education and Research) 01ZZ1804A (DIFUTURE)Consejería de Salud, Junta de Andalucía (Ministry of Health, Andalusian Regional Government) CTS-546Deutsche Forschungsgemeinschaft (German Research Foundation) NO246/10-2Deutsche Forschungsgemeinschaft (German Research Foundation) RI908/11-2EC | Horizon 2020 Framework Programme (EU Framework Programme for Research and Innovation H2020) EU RIA 733161 (MultipleMS)Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (Swiss National Science Foundation) 156791
6 · The paper itself

Abstract

The two major subtypes of bipolar disorder (BD), BD-I and BD-II, are distinguished based on the presence of manic or hypomanic episodes. Historically, BD-II was perceived as a less severe form of BD-I. Recent research has challenged this concept of a severity continuum. Studies in large samples of unrelated patients have described clinical and genetic differences between the subtypes. Besides an increased schizophrenia polygenic risk load in BD-I, these studies also observed an increased depression risk load in BD-II patients. The present study assessed whether such clinical and genetic differences are also found in BD patients from multiplex families, which exhibit reduced genetic and environmental heterogeneity. Comparing 252 BD-I and 75 BD-II patients from the Andalusian Bipolar Family (ABiF) study, the clinical course, symptoms during depressive and manic episodes, and psychiatric comorbidities were analyzed. Furthermore, polygenic risk scores (PRS) for BD, schizophrenia, and depression were assessed. BD-I patients not only suffered from more severe symptoms during manic episodes but also more frequently showed incapacity during depressive episodes. A higher BD PRS was significantly associated with suicidal ideation. Moreover, BD-I cases exhibited lower depression PRS. In line with a severity continuum from BD-II to BD-I, our results link BD-I to a more pronounced clinical presentation in both mania and depression and indicate that the polygenic risk load of BD predisposes to more severe disorder characteristics. Nevertheless, our results suggest that the genetic risk burden for depression also shapes disorder presentation and increases the likelihood of BD-II subtype development.

Indexed as

Bipolar DisorderSchizophreniaHumansMultifactorial InheritanceRisk FactorsSuicidal Ideation

Identifiers

PMID33431802
PMCPMC7801527
OpenAlexW3118904532

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.